Morgan Stanley
NEPT

Morgan Stanley’s Neptune Wellness Solutions Inc. Ordinary Shares NEPT Stock Holding History

Morgan Stanley’s Portfolio NEPT Stock Details NEPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,224
Closed -$14.5K – 8058
2023
Q4 		$14.5K Buy
27,224
+27,182
+64,719% +$20K ﹤0.01% 6752
2023
Q3 		$56 Sell
42
-13,574
-100% -$74K ﹤0.01% 7480
2023
Q2 		$80.1K Buy
13,616
+11
+0.1% +$157 ﹤0.01% 6036
2023
Q1 		$294K Sell
13,605
-16
-0.1% -$384 ﹤0.01% 5522
2022
Q4 		$172K Buy
13,621
+13,571
+27,142% +$511K ﹤0.01% 5732
2022
Q3 		$3K Buy
50
+1
+2% +$68 ﹤0.01% 7415
2022
Q2 		$3K Sell
49
-1
-2% -$203 ﹤0.01% 7543
2022
Q1 		$16K Sell
50
-35
-41% -$15.9K ﹤0.01% 7247
2021
Q4 		$49K Sell
85
-274
-76% -$188K ﹤0.01% 6828
2021
Q3 		$304K Buy
359
+258
+255% +$272K ﹤0.01% 5776
2021
Q2 		$166K Buy
101
+24
+31% +$43.5K ﹤0.01% 6109
2021
Q1 		$140K Sell
77
-871
-92% -$2.2M ﹤0.01% 5850
2020
Q4 		$2.07M Buy
948
+912
+2,533% +$2.34M ﹤0.01% 4127
2020
Q3 		$105K Buy
36
+3
+9% +$11.4K ﹤0.01% 5411
2020
Q2 		$130K Sell
33
-68
-67% -$228K ﹤0.01% 5282
2020
Q1 		$165K Buy
101
+2
+2% +$5.7K ﹤0.01% 4955
2019
Q4 		$382K Sell
99
-90
-48% -$391K ﹤0.01% 5085
2019
Q3 		$942K Buy
189
+40
+27% +$260K ﹤0.01% 4333
2019
Q2 		$909K Buy
149
+12
+9% +$68.4K ﹤0.01% 4270
2019
Q1 		$611K Buy
137
+22
+19% +$105K ﹤0.01% 4438
2018
Q4 		$407K Buy
115
+22
+24% +$107K ﹤0.01% 4917
2018
Q3 		$507K Buy
93
+45
+94% +$217K ﹤0.01% 4991
2018
Q2 		$207K Buy
48
+26
+118% +$105K ﹤0.01% 5523
2018
Q1 		$88K Sell
22
-7
-24% -$29K ﹤0.01% 5741
2017
Q4 		$96K Buy
29
+4
+16% +$7.26K ﹤0.01% 5644
2017
Q3 		$32K Buy
+25
New +$29.9K ﹤0.01% 5908
2017
Q2 		– Sell
-5
Closed -$8K – 6677
2017
Q1 		$8K Buy
5
+3
+150% +$4.42K ﹤0.01% 6276
2016
Q4 		$2K Sell
2
-1
-33% -$1.52K ﹤0.01% 6393
2016
Q3 		$5K Sell
3
-7
-70% -$9.94K ﹤0.01% 6247
2016
Q2 		$14K Buy
10
+6
+150% +$9.05K ﹤0.01% 5968
2016
Q1 		$6K Buy
4
+2
+100% +$2.99K ﹤0.01% 6251
2015
Q4 		$3K Sell
2
-7
-78% -$11.2K ﹤0.01% 6469
2015
Q3 		$14K Sell
9
-6
-40% -$11.1K ﹤0.01% 6163
2015
Q2 		$28K Buy
15
+1
+7% +$2.09K ﹤0.01% 6042
2015
Q1 		$32K Buy
14
+2
+17% +$4.98K ﹤0.01% 5935
2014
Q4 		$33K Buy
12
+10
+500% +$25K ﹤0.01% 5928
2014
Q3 		$5K Sell
2
-7
-78% -$21.1K ﹤0.01% 6333
2014
Q2 		$35K Sell
9
-31
-78% -$106K ﹤0.01% 5878
2014
Q1 		$139K Sell
40
-31
-44% -$127K ﹤0.01% 5289
2013
Q4 		$290K Sell
71
-43
-38% -$181K ﹤0.01% 4830
2013
Q3 		$506K Buy
114
+7
+7% +$35K ﹤0.01% 4321
2013
Q2 		$488K Buy
+107
New +$420K ﹤0.01% 4279

Other funds holding NEPT

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley's NEPT Position: Q1 2024 in Review

Morgan Stanley sold out of Neptune Wellness Solutions Inc. Ordinary Shares (NEPT) in Q1 2024, closing a stake of 27,224 shares — an estimated $14.5K sold.

Morgan Stanley first reported a position in NEPT in Q2 2013 and held it in 42 quarters. The position peaked at $2.07M in Q4 2020. 1 fund tracked by Wall St. Rank holds NEPT as of Q1 2024.

  • Morgan Stanley reported no remaining Neptune Wellness Solutions Inc. Ordinary Shares position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 27,224 Neptune Wellness Solutions Inc. Ordinary Shares shares in Q1 2024, an estimated $14.5K.
  • Morgan Stanley first reported a position in Neptune Wellness Solutions Inc. Ordinary Shares in Q2 2013 and held it in 42 quarters.
  • Morgan Stanley's Neptune Wellness Solutions Inc. Ordinary Shares position peaked at $2.07M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Neptune Wellness Solutions Inc. Ordinary Shares as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.